Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$532,169
-$3,735,590 QoQ
Shares Held
12,402
-88.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#132
of 217 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cinctive Capital Management LP holds $200,361,017 across 44 Biotechnology names. VERA ranks #38 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
350,165 | $46,477,400 | |
| 2 | INSM |
INSMED Inc
|
161,996 | $17,272,013 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,712 | $13,268,651 | |
| 4 | CYTK |
Cytokinetics Inc
|
137,838 | $11,742,419 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
226,140 | $8,003,094 | |
| 6 | NTHI |
Neonc Technologies Holdings, Inc.
|
1,607,464 | $7,281,811 | |
| 7 | ERAS |
Erasca, Inc.
|
391,642 | $7,174,881 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
16,367 | $6,083,122 |
All Filings in VERA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $532,169 | 12,402 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,267,759 | 106,084 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,272,204 | 64,617 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,806,411 | 96,573 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,818,675 | 162,083 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $633,263 | 26,364 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,801,860 | 113,546 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,143,700 | 48,500 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,258,050 | 34,772 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||